[go: up one dir, main page]

FI875608A7 - Stabila preparat av ricintoxin-a-kedja och rta-immunokonjugat och selektionsfoerfarande foer finnande av deras stabilisatorer. - Google Patents

Stabila preparat av ricintoxin-a-kedja och rta-immunokonjugat och selektionsfoerfarande foer finnande av deras stabilisatorer. Download PDF

Info

Publication number
FI875608A7
FI875608A7 FI875608A FI875608A FI875608A7 FI 875608 A7 FI875608 A7 FI 875608A7 FI 875608 A FI875608 A FI 875608A FI 875608 A FI875608 A FI 875608A FI 875608 A7 FI875608 A7 FI 875608A7
Authority
FI
Finland
Prior art keywords
och
stabilisatorer
selektionsfoerfarande
ricintoxin
immunokonjugat
Prior art date
Application number
FI875608A
Other languages
English (en)
Finnish (fi)
Other versions
FI875608A0 (fi
Inventor
Robert Ferris
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Corp filed Critical Cetus Corp
Publication of FI875608A0 publication Critical patent/FI875608A0/fi
Publication of FI875608A7 publication Critical patent/FI875608A7/fi

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/02Food
    • G01N33/14Beverages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817Toxins
    • A61K47/6819Plant toxins
    • A61K47/6825Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
    • A61K47/6827Ricin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/861Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgG3, IgG4, IgA, or IgY

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
FI875608A 1986-12-19 1987-12-18 Stabila preparat av ricintoxin-a-kedja och rta-immunokonjugat och selektionsfoerfarande foer finnande av deras stabilisatorer. FI875608A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/944,347 US4808705A (en) 1986-12-19 1986-12-19 Stable formulations of ricin toxin a chain and of RTA-immunoconjugates and stabilizer screening methods therefor

Publications (2)

Publication Number Publication Date
FI875608A0 FI875608A0 (fi) 1987-12-18
FI875608A7 true FI875608A7 (fi) 1988-06-20

Family

ID=25481236

Family Applications (1)

Application Number Title Priority Date Filing Date
FI875608A FI875608A7 (fi) 1986-12-19 1987-12-18 Stabila preparat av ricintoxin-a-kedja och rta-immunokonjugat och selektionsfoerfarande foer finnande av deras stabilisatorer.

Country Status (11)

Country Link
US (1) US4808705A (no)
EP (1) EP0271918A3 (no)
JP (1) JPS63258426A (no)
AU (1) AU593489B2 (no)
CA (1) CA1305417C (no)
DK (1) DK670587A (no)
FI (1) FI875608A7 (no)
HU (1) HUT45401A (no)
IE (1) IE873452L (no)
IL (1) IL84876A0 (no)
NO (1) NO875232L (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5393512A (en) * 1985-01-14 1995-02-28 Vanderheyden; Jean-Luc Stable therapeutic radionuclide compositions and methods for preparation thereof
US5116944A (en) * 1989-12-29 1992-05-26 Neorx Corporation Conjugates having improved characteristics for in vivo administration
US5270057A (en) * 1990-03-20 1993-12-14 Akzo N.V. Stabilized gonadotropin containing preparations
KR100361933B1 (ko) * 1993-09-08 2003-02-14 라 졸라 파마슈티칼 컴파니 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
CA2628053A1 (en) * 1997-11-07 1999-05-20 Conjuchem Biotechnologies Inc. Affinity markers for human serum albumin
US6458953B1 (en) * 1998-12-09 2002-10-01 La Jolla Pharmaceutical Company Valency platform molecules comprising carbamate linkages
US20070020662A1 (en) * 2000-01-07 2007-01-25 Transform Pharmaceuticals, Inc. Computerized control of high-throughput experimental processing and digital analysis of comparative samples for a compound of interest
US20070021929A1 (en) * 2000-01-07 2007-01-25 Transform Pharmaceuticals, Inc. Computing methods for control of high-throughput experimental processing, digital analysis, and re-arraying comparative samples in computer-designed arrays
EP1292337A2 (en) * 2000-06-08 2003-03-19 La Jolla Pharmaceutical Multivalent platform molecules comprising high molecular weight polyethylene oxide
PT1343518E (pt) * 2000-11-07 2009-08-03 Novartis Vaccines & Diagnostic Composições de interferão estabilizadas
DE60235013D1 (de) 2001-07-25 2010-02-25 Facet Biotech Corp Stabile lyophilisierte pharmazeutische formulierung des igg-antikörpers daclizumab
US20100210027A9 (en) * 2002-11-04 2010-08-19 Hongming Chen Method for determining effect of preformulation forms on their dissolution rates
WO2005009393A2 (en) * 2003-07-24 2005-02-03 Bracco Imaging S.P.A. Stable radiopharmaceutical compositions and methods for preparation
FR2877565A1 (fr) * 2004-11-09 2006-05-12 Oreal Utilisation d'un sulfate de dextran de haut poids moleculaire comme agent apaisant
WO2007016562A2 (en) * 2005-07-29 2007-02-08 Amgen Inc. Formulations that inhibit protein aggregation
EP1980853A1 (en) * 2007-04-11 2008-10-15 Alfresa Pharma Corporation Method of preventing precipitation of a reactive substance-bound microparticle, and reagent containing the micro particle
US20080261328A1 (en) * 2007-04-19 2008-10-23 Alfresa Pharma Corporation Method of preventing precipitation of a reactive substance-bound microparticle, and reagent containing the micro particle
KR101784231B1 (ko) 2008-06-20 2017-11-08 노파르티스 아게 응집이 감소된 면역글로불린
JP2013528570A (ja) 2010-03-31 2013-07-11 ユニベルシテ ドゥ ジュネーブ 安定化された抗体調製物およびその使用
WO2011121559A2 (en) 2010-03-31 2011-10-06 Universite De Geneve Stabilized antibody preparations and uses thereof
GB201717966D0 (en) 2017-10-31 2017-12-13 Xenikos Bv Immunotoxins, formulations thereof and their use in medicine
CN111781345A (zh) * 2020-06-30 2020-10-16 上海透景生命科技股份有限公司 化学发光标记物标记抗原稳定剂及其应用
CN119498456A (zh) * 2024-12-10 2025-02-25 山东海创工贸有限公司 一种利用奶制品和肉产品作为原料的宠物湿粮及其制作方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4623717A (en) * 1980-03-05 1986-11-18 Miles Laboratories, Inc. Pasteurized therapeutically active protein compositions
US4439181A (en) * 1981-01-26 1984-03-27 Regents Of The University Of Minnesota Polyol-hormone mixture for use in chronic parenteral hormone administration
JPS59116229A (ja) * 1982-12-24 1984-07-05 Teijin Ltd 細胞毒性複合体を活性成分とする癌治療用剤およびその製造法
US4664911A (en) * 1983-06-21 1987-05-12 Board Of Regents, University Of Texas System Immunotoxin conjugates employing toxin B chain moieties
DE3688137D1 (de) * 1985-11-29 1993-04-29 Consolidated Pharmaceuticals L Ricin-antikoerper-konjugate.

Also Published As

Publication number Publication date
DK670587D0 (da) 1987-12-18
JPS63258426A (ja) 1988-10-25
DK670587A (da) 1988-06-20
AU593489B2 (en) 1990-02-08
IE873452L (en) 1988-06-19
NO875232L (no) 1988-06-20
NO875232D0 (no) 1987-12-15
US4808705A (en) 1989-02-28
FI875608A0 (fi) 1987-12-18
EP0271918A2 (en) 1988-06-22
EP0271918A3 (en) 1989-12-13
HUT45401A (en) 1988-07-28
AU8280187A (en) 1988-06-23
IL84876A0 (en) 1988-06-30
CA1305417C (en) 1992-07-21

Similar Documents

Publication Publication Date Title
FI870834A0 (fi) Anordning och foerfarande foer hantering av mediciner.
FI864108L (fi) Nytt farmaceutiskt preparat och foerfarande foer framstaellning av detsamma.
FI875520A7 (fi) Foerpackning foer lagring och utmatning av fluider.
FI865334A7 (fi) Foerfarande och anordning foer smaeltning och raffinering av glasmaterial.
FI875313A7 (fi) Foerfarande och anordning foer framstaellning av fyllmedelshaltigt papper.
FI872850A7 (fi) Foerfarande foer framstaellning av imidazopyridiner och saosom mellanprodukter erhaollna foereningar.
FI884378L (fi) Farmaceutiskt preparat och foerfarande foer framstaellning av detsamma.
FI873993L (fi) Foerfarande och anordning foer behandling av avfallstryckpapper.
FI872021L (fi) Formade keramiska konstruktioner och foerfaranden foer tillverkning av dessa.
FI875608A7 (fi) Stabila preparat av ricintoxin-a-kedja och rta-immunokonjugat och selektionsfoerfarande foer finnande av deras stabilisatorer.
FI882707L (fi) Foerfarande och preparat foer hoejning av proteinhalten i mjoelk.
FI872936A0 (fi) Anordning och foerfarande foer plantering av plantor.
FI863393L (fi) Foderblandning och foerfarande foer framstaellning av densamma.
FI873924L (fi) Foerfarande foer framstaellning av aettiksyraestern av haloperidol och denna innehaollande farmaceutiska preparat.
FI874025L (fi) Modifierade keramiska strukturer och foerfaranden foer framstaellning av dessa.
FI864000L (fi) Foerfarande och anordning foer loesgoering av en elektrolytisk avlagrad utfaellning.
FI861761A7 (fi) Foerfarande och anordning foer framstaellning av mineralullsbana.
FI874866A0 (fi) Foerfarande foer framstaellning av antiallergiska och anti-inflammatoriska dihydropyridinderivat.
FI875101A0 (fi) Laktamderivat och preparat innehaollande dessa.
FI871765L (fi) Anordning och foerfarande foer konditionering av vatten.
FI860835A7 (fi) Foerfarande och anordning foer uppbromsning av en pappers- eller kartongmaskins maskinrulle.
FI874187L (fi) Foerfarande och anordning foer boejning av en glasskiva.
FI861839A0 (fi) Foerfarande foer skaerning av laongstraeckt betongstycke och skaerande verktyg.
FI870806L (fi) Sammansaettningar av konserveringsaemnen och anvaendning av desamma.
FI873066A7 (fi) Anordning och foerfarande foer odling av immobiliserade mikroorganismer.

Legal Events

Date Code Title Description
BB Publication of examined application
FD Application lapsed

Owner name: CETUS CORPORATION